References

1. Moutsopoulos HM, Chused TM, Mann DL, et al. Sjogren's syndrome (Sicca syndrome): current issues. Ann Int Med 1980;92:212-226.

2. Talal N. Clinical and pathogenetic aspects of Sjogren's syndrome. Semin Clin Immunol 1993;6:11-20.

3. Anaya JM, Gutierrez M, Espinosa LR. Síndrome de Sjögren primario. Manifestaciones clínicas ex-

traglandulares. Rev Esp Reumatol 1994;21:337-342.

Ramos M, Cervera R, García-Carrasco M, et al. Síndrome de Sjögren primario: características clínicas e inmunológicas en una serie de 80 pacientes. Med Clin (Bare) 1997;108:652-657. Moutsopoulos HM. Sjogren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol 1994;72:162-165.

Rothman S, Bloch M, Hauser FV. Sjogren's syndrome associated with lymphoblastoma and hyper-splenism. Arch Dermatol e Syph 1951 ;63:642. Talal N, Bunim JJ. Development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med 1964;36:529-540.

Hornbaker JH Jr, Foster EA, Williams GS, Davis JS. Sjogren's syndrome and nodular reticulum cell sarcoma. Arch Int Med 1966; 118:449452.

Miller DG. The association of immune disease and malignant lymphoma. Ann Int Med 1967;66:507-521.

Anderson LG, Talal N. The spectrum of benign to malignant lymphoproliferation in Sjogren's syndrome. Clin Exp Immunol 1972;10:199-221. Hughes GR, Whaley K. Sjogren's syndrome. Br Med J 1972;4:533-536.

Perez Pe:a F, Gonzalez AA, Candel Monserrate I. Relación existente entre el síndrome de Sjögren y los linfomas malignos. Rev Clin Esp 1974; 133:465470.

Faguet GB, Webb HH, Agee JF, Ricks WB, Sharbaugh AH Immunologically diagnosed malignancy in Sjogren's pseudolymphoma. Am J Med 1978;65:424-429.

Zulman J, Jaffe R, Talal N Evidence that the malignant lymphoma of Sjogren's syndrome is a monoclonal B-cell neoplasm. N Engl J Med 1978;299:1215-1220.

Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Int Med 1978;89:888-892.

Kruize AA, Hené RJ, Van der Heide A, et al. Long-term follow-up of patients with Sjogren's syndrome. Arthrit Rheum 1996;39:297-303. Valesini G, Priori R, Bavoillot D, et al. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjogren's syndrome. J Rheumatol 1997;24:2376-380.

Kauppi M, Pukkala E, Isomaki H. Elevated incidence of hematologic malignancies in patients with Sjogren's syndrome compared with patients with rheumatoid arthritis. Cancer Causes Control 1997;8:201-204.

19. Ramos-Casals M, Cervera R, Font J, et al. Young onset of primary Sjogren's syndrome: clinical and immunological characteristic. Lupus 1998;7:202-206.

20. Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjogren's syndrome: a clinical, pathological and serological study of sixty-two cases. Medicine 1965;44:187-231.

21. McCurley TL, Collins RD, Ball E, Collins RD. Nodal and extranodal lymphoproliferative disorders in Sjogren's syndrome: a clinical and immunopatho-logic study. Hum Pathol 1990;21:482-492.

22. Kelly CA, Foster H, Pal B, et al. Primary Sjogren's syndrome in north east England. A longitudinal study. Br J Rheumatol 1991 ;30:437^42.

23. Pariente D, Anaya JM, Combe B, et al. Non-Hodgkin's lymphoma associated with primary Sjogren's syndrome. Eur J Med 1992;l(6):337-342.

24. Pavlidis NA, Drosos AA, Papadimitriou C, Talal N, Moutsopoulos HM. Lymphoma in Sjogren's syndrome. Med Pediatr Oncol 1992;20:279-283.

25. Zufferey P, Meyer OC, Grossin M, Kahn MF. Primary Sjogren's syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol 1995;24:342-345.

26. Hernandez JA, Olive A, Ribera JM, Tena X, Cuxart A, Feliu E. Probability of the development of non-Hodgkin's lymphoma in primary Sjogren's syndrome. Scand J Rheumatol 1996;25:396-397.

27. Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive id-iotypes as predictive factors for the development of lymphoma in primary Sjogren's syndrome. Arthrit Rheum 1996;39:767-772.

28. Shearn M. Sjogren's syndrome. Philadelphia: WB Saunders, 1971.

29. Whaley K, Webb J, McAvoy BA, et al. Sjogren's syndrome. II. Clinical associations and immunological phenomena. Quart J Med 1973;42:513-548.

30. Dolcetti R, Boiocchi M. Cellular and molecular bases of B-cell clonal expansions. Clin Exp Rheumatol 1996;14(suppl 14):S3-S13.

31. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: A proposal from the international lymphoma study group. Blood 1994;84:1361-1392.

32. Graninger WB, Seton B, Boutain B, et al. Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 1987;80:1512.

33. Fox RI, Robinson C, Pisa P, Pisa E. Detection of bcl-2t (14,18) translocations in Sjogren's syndrome lymphoma. Clin Exp Rheumatol 1991;9:333 (abstract).

Pisa EK, Pisa P, Kang HI, Fox RI High frequency of t(14;18) translocation in salivary gland lymphomas from Sjogren's syndrome patients. J Exp Med 1991;174:1245-1250. Jordan RC, Pringle JH, Speight PM High frequency of light chain restriction in labial gland biopsies of Sjogren's syndrome detected by in situ hybridization. J Pathol 1995;177(l):35-40. Bosch F, Jares P, Campo E, et al. PRAD-l/cyclin D1 gene overexpression in chronic lymphoprolifer-ative disorders: a high specific marker of mantle cell lymphoma. Blood 1994;84:2726-2732. Dielermann J, Pittaluga S, Wlodarska I, et al. Marginal zone B-cell lymphomas of different sites share similar cytogenetic and morphologic features. Blood 1996;87:299.

Du M, Pengh H, Singh N, Isaacson PG, Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood 1995;86:4587.

Guo K, Major G, Foster H, et al. Defective repair of 06-methylguanine-DNA in primary Sjogren's syndrome patients predisposed to lymphoma. Ann

Rheum Dis 1995;54:229-232.

Kirschner H, Tosato G, Blaese RM, et al. Polyclonal immunoglobulin secretion by human B lymphocytes exposed to Epstein-Barr virus in vitro. J Immunol

1979;122:1310-1313.

Morgan DG, Niederman JC, Miller G, et al. Site of Epstein-Barr virus replication in the oropharynx. Lancet 1979;1:1154-1157.

Mariette X, Gozlan J, Clerc D, et al. Detection of Epstein-Barr virus DNA by in situ hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome. Am J Med 1991;90:286.

Fox RI, Chen P, Carson DA, Fong S. Expression of a cross-reactive idiotype on rheumatoid factor in patients with Sjogren's syndrome. J Immunol 1986; 136:477^183.

Fox RI, Scott S, Houghton R, et al. Synthetic peptide derived from the Epstein-Barr virus encoded early diffuse antigen (EA-D) reactive with human antibodies. J Clin Lab Anal 1987;1:140-145. Fox RI, Saito I, Chan EK, et al. Viral genomes in lymphomas of patients with Sjogren's syndrome. J Autoimmun 1989;2:449-455. Jeffers M, Crilly A, Kerr T, Richmond J, Madhok R. Non-Hodgkin's lymphomas complicating Sjogren's syndrome: can Epstein Barr virus be implicated? Scand J Rheumatol 1997;26:180-183. Royer B, Cazals-Hatem D, Sibilia J, et al. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse ex-

tranodal and nodal sites, and are not associated with viruses. Blood 1997;90:766-775.

48. Fox RI, Saito I, Chan EK, Josephs S, Salahuddin SZ, Ahlashi DV, Staal FW, Gallo R, Pei-Ping H, Le CS. Viral genomes in lymphomas of patients with Sjogren's syndrome. J Autoimmun 1989;2:449-455.

49. Freimark B, Fantozzi R, Bone R, Bordin G, Fox R. Detection of clonally expanded salivary gland lymphocytes in Sjogren's syndrome. Arthrit Rheum 1989;32:859-869.

50. Miyasaka N, Saito I, Haruta J. Possible involvement of Epstein-Barr virus in the pathogenesis of Sjogren's syndrome. Clin Immunol Immunopathol 1994;72:166-170.

51. Saito I, Nishimura S, Kudo I, Fox RI, Moro I. Detection of Epstein-Barr virus and human herpes virus type 6 in saliva from patients with lymphoprolifera-tive diseases by the polymerase chain reaction. Arch Oral Biol 1991;36:779-784.

52. Jarrett RF, Gledhill S, Qureshi F, et al. Identification of human herpesvirus 6-specific DNA sequences in two patients with non-Hodgkin's lymphoma. Leukemia 1988;2:496-502.

53. Fox RI, Luppi M, Kang HI, Ablshi D, Josephs S. Detection of high levels of human herpes virus-6 DNA in a lymphoma of a patient with Sjogren's syndrome. J Rheumatol 1993;20(4):764-765.

54. Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjogren's Syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.

55. García-Carrasco M, Ramos M, Cervera R, et al. Hepatitis C virus infection in "primary" Sjogren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis 1997;56:1-3.

56. Jorgensen C, Legouffe MC, Perney P, et al. Sicca syndrome associated with hepatitis C virus infection. Arthrit Rheum 1996;39:1166-1171.

57. Koike K, Moriya K, Ishibashi K, et al. Sialadenitis histologically resembling Sjogren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997;94:233-236.

58. Koike K, Moriya K, Ishibashi K, et al. Expression of hepatitis C virus envelope proteins in transgenic mice. J Gen Virol 1995;76:3031-3038.

59. Heimann R. Cirrhosis and lymphoproliferative disorders. Lancet 1971;ii:101.

60. Ferri C, La Civita L, Caracciolo F, Zignego AL. Non-Hodgkin's lymphoma: a possible role of hepatitis C virus infection. JAMA 1994;272:355-356.

61. Ferri C, Caracciolo F, Zignego AL, et al. Hepatitis C virus infection in patients with non-Hodgkin lymphoma. Br J Haematol 1994;88:392-394.

Pozzato G, Mazzaro C, Santini GF, Burrone O.

Nepatitis C virus and non-Hodgkin's lymphoma.

Leuk Lymphoma 1996;22:53.

Silvestri F, Pipan C, Barillari G, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996;87:

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment